Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis

Arthritis and Rheumatology - Tập 70 Số 7 - Trang 984-999 - 2018
Jane Falconer1, Anne N. Murphy2, Stephen P. Young2, Andrew R. Clark3, Stefano Tiziani4, Mònica Gumà2,5, Christopher D. Buckley6,7
1University of Birmingham Queen Elizabeth Hospital and National Institute for Health Research Birmingham Biomedical Research Centre Birmingham UK
2Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK
3University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK
4University of Texas at Austin
5The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK
6University of Birmingham Queen Elizabeth Hospital National Institute for Health Research Birmingham Biomedical Research Centre Birmingham UK
7University Of Oxford, Oxford, UK

Tóm tắt

Metabolomic studies of body fluids show that immune‐mediated inflammatory diseases such as rheumatoid arthritis (RA) are associated with metabolic disruption. This is likely to reflect the increased bioenergetic and biosynthetic demands of sustained inflammation and changes in nutrient and oxygen availability in damaged tissue. The synovial membrane lining layer is the principal site of inflammation in RA. Here, the resident cells are fibroblast‐like synoviocytes (FLS) and synovial tissue macrophages, which are transformed toward overproduction of enzymes that degrade cartilage and bone and cytokines that promote immune cell infiltration. Recent studies have shown metabolic changes in both FLS and macrophages from RA patients, and these may be therapeutically targetable. However, because the origins and subset‐specific functions of synoviocytes are poorly understood, and the signaling modules that control metabolic deviation in RA synovial cells are yet to be explored, significant additional research is needed to translate these findings to clinical application. Furthermore, in many inflamed tissues, different cell types can forge metabolic collaborations through solute carriers in their membranes to meet a high demand for energy or biomolecules. Such relationships are likely to exist in the synovium and have not been studied. Finally, it is not yet known whether metabolic change is a consequence of disease or whether primary changes to cellular metabolism might underlie or contribute to the pathogenesis of early‐stage disease. In this review article, we collate what is known about metabolism in synovial tissue cells and highlight future directions of research in this area.

Từ khóa


Tài liệu tham khảo

10.4049/jimmunol.1601318

10.1016/j.coi.2017.04.006

10.1016/0306-9877(84)90162-2

10.1136/ard.38.1.63

10.1038/nrrheum.2012.190

10.1186/s13075-017-1303-3

10.1111/j.1365-2249.2012.04634.x

10.1038/nri.2016.70

10.1016/j.berh.2014.10.022

Juarez M, 2012, Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer, Swiss Med Wkly, 142, w13529

10.1136/ard.2006.068403

Cojocaru M, 2012, Metabolic syndrome in rheumatoid arthritis, Mædica, 7, 148

10.1093/ajcn/65.3.876

10.1038/nrrheum.2016.1

10.1186/s12916-016-0681-8

10.1002/art.38021

10.1186/ar3243

Hugle T, 2012, Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy, Clin Exp Rheumatol, 30, 240

10.1371/journal.pone.0097501

10.1371/journal.pone.0163087

10.1136/rmdopen-2016-000289

10.1186/s12891-016-1214-5

10.2174/1874312901105010100

10.1016/j.celrep.2014.09.032

10.1038/nrrheum.2016.91

10.1038/nrrheum.2012.190

10.1186/s13075-016-1156-1

Mizoguchi F, 2015, Identification of synovial fibroblast subsets that define pathology in rheumatoid arthritis [abstract], Arthritis Rheumatol, 67

10.1038/nature01661

10.1111/j.0105-2896.2009.00859.x

10.1002/art.30395

10.1136/ard.2004.031641

10.1080/08916930903143083

10.1016/j.jbspin.2015.11.009

10.1136/annrheumdis-2014-205696

10.1136/rmdopen-2017-000527

10.1016/j.coi.2017.04.010

10.1007/978-1-4939-6931-9_16

10.1038/nature13312

10.1371/journal.pbio.1000514

10.1038/nature11862

10.1038/nri3901

10.1016/j.molcel.2013.01.019

10.1038/onc.2014.301

10.1016/j.smim.2015.08.001

10.1371/journal.pone.0140452

10.3389/fimmu.2017.01135

10.1136/ard.2010.132720

10.1042/bse0470069

10.1016/j.beem.2012.05.003

10.1016/j.it.2011.01.005

10.1016/j.tem.2015.12.001

10.1242/jcs.070490

10.1172/JCI84431

10.1016/j.tcb.2013.11.008

10.1016/j.cmet.2016.06.004

10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7

10.1038/cddis.2016.490

10.1136/annrheumdis-2015-208476

10.1002/art.39608

10.1038/nrrheum.2016.69

10.1136/ard.2009.119776

10.1186/ar1752

10.1136/annrheumdis-2011-200245

10.1038/nri846

10.1016/j.tibs.2015.01.004

10.1074/mcp.M112.025775

10.1007/s00011-012-0572-1

10.1038/srep32928

10.1186/ar2921

10.1126/science.1160809

10.1038/nrc1478

10.1007/s12149-009-0305-x

10.1038/nrrheum.2017.49

Volchenkov R, 2016, Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples, Scand J Rheumatol, 1

10.1084/jem.20130252

10.1016/j.jbspin.2015.11.009

10.3389/fimmu.2016.00532

10.1016/j.cell.2013.05.016

10.1038/onc.2016.410

10.1016/j.celrep.2015.05.046

10.1038/ni.3366

10.1002/art.11282

10.1080/14397595.2017.1280118

10.1074/jbc.M303789200

10.1016/j.imlet.2016.04.001

10.1016/j.clinbiochem.2005.06.006

Bourgoin SG, 2010, Autotaxin and lysophospholipids in rheumatoid arthritis, Curr Opin Investig Drugs, 11, 515

10.1186/s13075-014-0461-9

10.1084/jem.20112012

10.1002/cphy.c130008

10.4161/cc.8.23.10238

10.1089/ars.2011.4243

10.1158/0008-5472.CAN-10-2828

10.1002/art.39270

10.1186/1471-2407-14-154

Metallo CM, 2015, Metabolic analysis using stable isotopes

10.1016/j.copbio.2010.08.009

10.1016/j.tibtech.2004.12.001

10.1038/nm.3416

10.1016/j.ccell.2014.12.002

10.1021/ac300611n

10.1371/journal.pone.0145539

10.1038/nrrheum.2016.184

10.1038/nrd4145

10.1136/ard.62.6.568

10.1016/j.cyto.2005.06.002

10.1016/j.ccr.2013.08.020

10.1016/j.cell.2016.05.035

10.1155/2014/973986

10.2147/OTT.S89967

10.1016/j.cmet.2013.11.008

10.1136/annrheumdis-2014-206993